Compound: SB505124

Drug Target: TGFBR1, ACVR1B, ACVR1C

Drug Target pathway: RTK signaling

Dataset


Tissue specific analysis

Contact us | Cookies policy | Terms & Conditions. This site is hosted by the Wellcome Sanger Institute.